Want to see HYEX full AI Analyst Report?
HYEX Stock Chart & Stats
$1.97
$0.00(0.00%)
At close: 4:00 PM EST
$1.97
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.81 - $3.35
Previous CloseN/A
Volume1.00
Average Volume (3M)1.29K
Market Cap
$37.16M
Enterprise Value$10.55M
Total Cash (Recent Filing)$164.38K
Total Debt (Recent Filing)$2.56M
Price to Earnings (P/E)―
Beta1.68
Next Earnings
Aug 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding16,890,867
10 Day Avg. Volume902
30 Day Avg. Volume1,290
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)0.59
Price to Sales (P/S)3.13
P/FCF Ratio96.73
Enterprise Value/Market Cap0.28
Enterprise Value/Revenue2.03
Enterprise Value/Gross Profit3.53
Enterprise Value/Ebitda-19.80
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.13
Revenue Forecast (FY)$14.12M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained TTM revenue growth indicates improving product traction and market demand. Over a 2–6 month horizon this trend supports higher scale economics, better negotiating leverage with suppliers, and provides a foundation for margin expansion if operating expenses are controlled.
Gross MarginA ~54% gross margin is a structural strength for a specialty drug/wellness manufacturer, providing durable product-level profitability. This margin room supports investments in marketing and R&D while making it easier to reach operating break-even as fixed costs are leveraged with incremental revenue.
Improving Cash GenerationConversion to positive operating and free cash flow, with strong FCF growth, signals improving cash conversion and operational discipline. Free cash flow close to net loss magnitude implies real cash generation that can fund near-term operations or small strategic investments without immediate reliance on external capital.
Bears Say
Persistent UnprofitabilityNegative operating and net margins around -19% show the business still requires significant expense leverage or revenue growth to hit sustainable profitability. Over the medium term this constrains reinvestment, reduces retained earnings, and keeps dependence on external funding if losses persist.
Weak Cash-Flow CoverageAlthough cash flows are positive, the absolute levels are small and the coverage ratio (~0.10) indicates limited ability to meet obligations or absorb shocks. This structural weakness reduces flexibility for capex, M&A integration, or weathering revenue volatility without external liquidity support.
Leadership TurnoverThe resignation of the President/COO (and a separate CBO exit) creates governance and execution risk at a critical time post-acquisition. Durably, vacant senior roles can slow strategic decisions, integration of acquisitions, and brand/operational initiatives, increasing execution uncertainty over the coming months.
Healthy Extracts News
HYEX FAQ
What was Healthy Extracts’s price range in the past 12 months?
Healthy Extracts lowest stock price was $0.81 and its highest was $3.35 in the past 12 months.
What is Healthy Extracts’s market cap?
Healthy Extracts’s market cap is $37.16M.
When is Healthy Extracts’s upcoming earnings report date?
Healthy Extracts’s upcoming earnings report date is Aug 17, 2026 which is in 34 days.
How were Healthy Extracts’s earnings last quarter?
Healthy Extracts released its earnings results on May 14, 2026. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Healthy Extracts overvalued?
According to Wall Street analysts Healthy Extracts’s price is currently Overvalued.
Does Healthy Extracts pay dividends?
Healthy Extracts does not currently pay dividends.
What is Healthy Extracts’s EPS estimate?
Healthy Extracts’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Healthy Extracts have?
Healthy Extracts has 16,890,867 shares outstanding.
What happened to Healthy Extracts’s price movement after its last earnings report?
Healthy Extracts reported an EPS of -$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Healthy Extracts?
Currently, no hedge funds are holding shares in HYEX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Healthy Extracts
Healthy Extracts Inc., through its various divisions, specializes in the global and domestic research, development, and sale of natural botanical products. Its portfolio encompasses dietary supplements crafted for cardiovascular wellness, alongside KETONOMICS-branded neuro-enhancers aimed at boosting cognitive functions like memory, mental acuity, concentration, and neural energy. The company further supplies encapsulated bergamot products, available under distinct labels such as BergaMet Pro+, BergaMet Mega+O, BergaMet HERHEART, BergaMet Cholesterol Command, and BergaMet SPORTSHEART. These bergamot offerings are distributed via its online platform and various other channels. Established in 2014 and based in Littleton, Colorado, the company was previously known as Grey Cloak Tech Inc. until its name change in October 2020.
Technical Analysis
Rockwell Med
―
SCYNEXIS
―
Aytu BioScience
―
Cumberland Pharmaceuticals
―
Cosmos Holdings
―
Ownership Overview
Options Prices
Currently, No data available
---